13.4.2026 | RED DOT
Marginum wins the prestigious Red Dot Design Award for HIVEN® device, recognising its innovation in advancing cancer surgery through user-centred design.
30.3.2026 | MARGINUM NEWS
Marginum launches a U.S. clinical study with the HIVEN® device at the University of Illinois Hospital & Clinics (UI Health) in Chicago.
19.3.2026 | Marginum News
ALMEDA, a Prague-based medical equipment distributor, has partnered with Marginum to distribute its HIVEN® device in the Czech Republic and Slovakia.
26.2.2026 | Neuro-Oncology Advances
A first-in-human study shows that HIVEN®-based aspirate tissue monitoring provides nearly 5 times more fluorescence information than visual guidance alone.
17.12.2025 | THE FINNISH MEDICAL FOUNDATION
CEO Samu Lehtonen has been nominated for the prestigious Pohjola Medical Innovation Award in recognition of the Marginum team’s scientific contributions.
3.11.2025 | BUSINESS FINLAND
Marginum has been selected for the prestigious Young Innovative Companies (YIC) program, a recognition reserved for Finland’s most promising startups.
20.10.2025 | MARGINUM NEWS
Marginum has completed the HIVEN® usability assessment at the University of Illinois College of Medicine Surgical Innovation and Training Laboratory.
15.10.2025 | Marginum News
Thomy F.E., d.o.o., one of Slovenia’s leading distributors of advanced medical and surgical technologies, has formed a strategic partnership with Marginum.
3.10.2025 | Redacción Médica
MBA SURGICAL EMPOWERMENT, a leading Spanish distributor in the medical-surgical technology sector, has partnered with Marginum.
25.9.2025 | BUSINESS WIRE
Marginum receives MDR certification and releases the first-of-a-kind HIVEN® device, bringing the technology to clinical use in the EU.